BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 10417659)

  • 1. REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
    Tolnay M; Probst A
    Neuropathol Appl Neurobiol; 1999 Jun; 25(3):171-87. PubMed ID: 10417659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau protein pathology in neurodegenerative diseases.
    Spillantini MG; Goedert M
    Trends Neurosci; 1998 Oct; 21(10):428-33. PubMed ID: 9786340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
    Botez G; Probst A; Ipsen S; Tolnay M
    Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitration of tau protein is linked to neurodegeneration in tauopathies.
    Horiguchi T; Uryu K; Giasson BI; Ischiropoulos H; LightFoot R; Bellmann C; Richter-Landsberg C; Lee VM; Trojanowski JQ
    Am J Pathol; 2003 Sep; 163(3):1021-31. PubMed ID: 12937143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
    Forman MS; Lee VM; Trojanowski JQ
    J Chem Neuroanat; 2000 Dec; 20(3-4):225-44. PubMed ID: 11207421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
    Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
    FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.
    Rawat P; Sehar U; Bisht J; Selman A; Culberson J; Reddy PH
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative tauopathies.
    Lee VM; Goedert M; Trojanowski JQ
    Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau and tauopathies.
    Robert M; Mathuranath PS
    Neurol India; 2007; 55(1):11-6. PubMed ID: 17272893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration.
    Sahara N; Maeda S; Takashima A
    Curr Alzheimer Res; 2008 Dec; 5(6):591-8. PubMed ID: 19075586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
    Sergeant N; Wattez A; Delacourte A
    J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontotemporal lobar degeneration. An update on clinical, pathological and genetic findings.
    Tolnay M; Probst A
    Gerontology; 2001; 47(1):1-8. PubMed ID: 11244285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau-based treatment strategies in neurodegenerative diseases.
    Schneider A; Mandelkow E
    Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of tau PET molecular imaging.
    Cassinelli Petersen G; Roytman M; Chiang GC; Li Y; Gordon ML; Franceschi AM
    Curr Opin Neurol; 2022 Apr; 35(2):230-239. PubMed ID: 35191407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.